Ferrari NV
F:2FE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Ferrari NV
F:2FE
|
IT |
|
SGS SA
OTC:SGSOF
|
CH |
|
H
|
HCA Healthcare Inc
XMUN:2BH
|
US |
|
Novartis AG
F:NOT
|
CH |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2FE's stock price target?
Price Target
404.65
EUR
According to Wall Street analysts, the average 1-year price target for 
2FE is 404.65 EUR with a low forecast of 331.34 EUR and a high forecast of 480.15 EUR.
What is the Revenue forecast for Ferrari NV?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 7%.
What is the Gross Profit forecast for Ferrari NV?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Ferrari NV?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Ferrari NV?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Ferrari NV?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 8 years is 8%.